Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 190 pseudogene (RNU7-190P) is classified as a pseudogene of the U7 small nuclear RNA (snRNA) gene family[2]. Pseudogenes are genomic DNA sequences similar to normal genes but are generally non-functional; they do not produce functional proteins or RNAs[8][2]. The genuine U7 snRNA plays a key role in the 3’ end processing of replication-dependent histone pre-mRNAs and is a component of the U7 small nuclear ribonucleoprotein (snRNP) complex, which is essential for histone mRNA maturation in eukaryotes[1][3][6]. However, as a pseudogene, RNU7-190P does not encode functional U7 snRNA or contribute to this process[2]. There are no documented roles for RNU7-190P in human biology, no evidence of its relevance in disease, nor is it known to interact with drugs or serve as a therapeutic target[2]. Pseudogenes like RNU7-190P are not considered targets for therapy because they are typically “dead” copies of active genes and lack known biological or clinical significance[8][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 190 pseudogene (RNU7-190P).